Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2018-10-16

Clinical Trial Update: Carboplatin and ABI-007 in Treating Patients With Stage IV Melanoma That Cannot Be Removed By Surgery [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating carboplatin with ABI-007 (nab-paclitaxel) in stage IV melanoma not amenable to surgery; study completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • ABI-007 (nab-paclitaxel)
  • CARBOPLATIN (Carboplatin)

Snippet

Sponsor: Alliance for Clinical Trials in Oncology | Conditions: Melanoma (Skin) | Phase 2 | Status: COMPLETED | Results posted: 2018-10-16